Development of a highly sensitive latex reagent directed against C-reactive protein (CRP) using epitope analysis with monoclonal antibodies. 2010

Tomoe Komoriya, and Maho Kikuchi, and Yutaka Terashima, and Mayumi Okamoto, and Masahiro Ogawa, and Mituhiko Moriyama, and Hideki Kohno
College of Industrial Technology, Nihon University, Nerashino, Chiba, Japan.

C-Reactive protein (CRP) is an acute-phase protein that increases during systemic inflammation and is currently one of the most frequently studied inflammatory markers in epidemiology. We have determined CRP concentration using novel latex reagent with polyclonal antibody. In the present study, we determined the concentration of CRP using monoclonal antibodies, and evaluated the interaction of antigen-antibody reactive sites and latex agglutination to detect low CRP concentrations. We developed four novel monoclonal antibodies that we classified into two major groups, and that were used to prepare the latex reagents. The latex reagents prepared using a cocktail of monoclonal antibodies for different epitopes appeared highly sensitive. The lower limit of CRP detection, which was defined using the mean 3 SD method, was calculated to be 5 ng/ml for the latex reagents when oligoclonal antibodies were utilized. Furthermore, the latex reagents were found to react specifically with CRP in clinical samples.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007840 Latex A milky, product excreted from the latex canals of a variety of plant species that contain cauotchouc. Latex is composed of 25-35% caoutchouc, 60-75% water, 2% protein, 2% resin, 1.5% sugar & 1% ash. RUBBER is made by the removal of water from latex.(From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed). Hevein proteins are responsible for LATEX HYPERSENSITIVITY. Latexes are used as inert vehicles to carry antibodies or antigens in LATEX FIXATION TESTS. Latices,Latice
D007841 Latex Fixation Tests Passive agglutination tests in which antigen is adsorbed onto latex particles which then clump in the presence of antibody specific for the adsorbed antigen. (From Stedman, 26th ed) Latex Agglutination Tests,Agglutination Test, Latex,Agglutination Tests, Latex,Fixation Test, Latex,Fixation Tests, Latex,Latex Agglutination Test,Latex Fixation Test,Test, Latex Agglutination,Test, Latex Fixation,Tests, Latex Agglutination,Tests, Latex Fixation
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic

Related Publications

Tomoe Komoriya, and Maho Kikuchi, and Yutaka Terashima, and Mayumi Okamoto, and Masahiro Ogawa, and Mituhiko Moriyama, and Hideki Kohno
December 1987, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
Tomoe Komoriya, and Maho Kikuchi, and Yutaka Terashima, and Mayumi Okamoto, and Masahiro Ogawa, and Mituhiko Moriyama, and Hideki Kohno
October 2011, Journal of immunological methods,
Tomoe Komoriya, and Maho Kikuchi, and Yutaka Terashima, and Mayumi Okamoto, and Masahiro Ogawa, and Mituhiko Moriyama, and Hideki Kohno
November 2012, Journal of bioscience and bioengineering,
Tomoe Komoriya, and Maho Kikuchi, and Yutaka Terashima, and Mayumi Okamoto, and Masahiro Ogawa, and Mituhiko Moriyama, and Hideki Kohno
November 1974, Clinical immunology and immunopathology,
Tomoe Komoriya, and Maho Kikuchi, and Yutaka Terashima, and Mayumi Okamoto, and Masahiro Ogawa, and Mituhiko Moriyama, and Hideki Kohno
April 1988, Hybridoma,
Tomoe Komoriya, and Maho Kikuchi, and Yutaka Terashima, and Mayumi Okamoto, and Masahiro Ogawa, and Mituhiko Moriyama, and Hideki Kohno
August 1990, Kaku igaku. The Japanese journal of nuclear medicine,
Tomoe Komoriya, and Maho Kikuchi, and Yutaka Terashima, and Mayumi Okamoto, and Masahiro Ogawa, and Mituhiko Moriyama, and Hideki Kohno
September 1984, Revista espanola de fisiologia,
Tomoe Komoriya, and Maho Kikuchi, and Yutaka Terashima, and Mayumi Okamoto, and Masahiro Ogawa, and Mituhiko Moriyama, and Hideki Kohno
February 1995, Nihon rinsho. Japanese journal of clinical medicine,
Tomoe Komoriya, and Maho Kikuchi, and Yutaka Terashima, and Mayumi Okamoto, and Masahiro Ogawa, and Mituhiko Moriyama, and Hideki Kohno
October 1985, Journal of immunological methods,
Tomoe Komoriya, and Maho Kikuchi, and Yutaka Terashima, and Mayumi Okamoto, and Masahiro Ogawa, and Mituhiko Moriyama, and Hideki Kohno
June 1992, Infection and immunity,
Copied contents to your clipboard!